CA2534515A1 - A surgically implantable injection port having an absorbable fastener - Google Patents
A surgically implantable injection port having an absorbable fastener Download PDFInfo
- Publication number
- CA2534515A1 CA2534515A1 CA002534515A CA2534515A CA2534515A1 CA 2534515 A1 CA2534515 A1 CA 2534515A1 CA 002534515 A CA002534515 A CA 002534515A CA 2534515 A CA2534515 A CA 2534515A CA 2534515 A1 CA2534515 A1 CA 2534515A1
- Authority
- CA
- Canada
- Prior art keywords
- housing
- injection port
- attachment mechanism
- port
- attached
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/005—Gastric bands
- A61F5/0053—Gastric bands remotely adjustable
- A61F5/0056—Gastric bands remotely adjustable using injection ports
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04M—TELEPHONIC COMMUNICATION
- H04M1/00—Substation equipment, e.g. for use by subscribers
- H04M1/02—Constructional features of telephone sets
- H04M1/0202—Portable telephone sets, e.g. cordless phones, mobile phones or bar type handsets
- H04M1/026—Details of the structure or mounting of specific components
- H04M1/0266—Details of the structure or mounting of specific components for a display module assembly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0208—Subcutaneous access sites for injecting or removing fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0208—Subcutaneous access sites for injecting or removing fluids
- A61M2039/0223—Subcutaneous access sites for injecting or removing fluids having means for anchoring the subcutaneous access site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0208—Subcutaneous access sites for injecting or removing fluids
- A61M2039/0232—Subcutaneous access sites for injecting or removing fluids having means for facilitating the insertion into the body
Abstract
An implantable surgical injection port having an undeployed position, and a deployed position wherein it is attached to tissue. The port includes a housing having a closed distal end, a open proximal end and a fluid reservoir therebetween.
The port further includes a needle penetrable septum attached to the housing about the opening. The port even further includes at least one attachment mechanism mounted to the housing for initially attaching the port to tissue wherein the attachment mechanism is made from a bioabsorbable material.
The port further includes a needle penetrable septum attached to the housing about the opening. The port even further includes at least one attachment mechanism mounted to the housing for initially attaching the port to tissue wherein the attachment mechanism is made from a bioabsorbable material.
Description
A SURGICALLY IMPLANTABLE INJECTION PORT HAVING AN
ABSORBABLE FASTENER
[0001] Field of the Invention [0002] The present invention has application in conventional endoscopic and open surgical instrumentation as well as application in robotic-assisted surgery. The present invention has even further relation to adjustable surgically implantable bands, such as gastric bands for the treatment of obesity.
ABSORBABLE FASTENER
[0001] Field of the Invention [0002] The present invention has application in conventional endoscopic and open surgical instrumentation as well as application in robotic-assisted surgery. The present invention has even further relation to adjustable surgically implantable bands, such as gastric bands for the treatment of obesity.
[0003] Background of the Invention [0004] The percentage of the world's population suffering from morbid obesity is steadily increasing. Severely obese persons are susceptible to increased risk of heart disease, stroke, diabetes, pulmonary disease, and accidents. Because of the effect of morbid obesity to the life of the patient, methods of treating morbid obesity are being researched.
[OOOS] Numerous non-operative therapies for morbid obesity have been tried with virtually no permanent success. Dietary counseling, behavior modification, wiring a patient's jaws shut, and pharmacological methods have all been tried, and failed to correct the condition. Mechanical apparatuses for insertion into the body through non-surgical means, such as the use of gastric balloons to fill the stomach have also been employed in the treatment of the condition. Such devices cannot be employed over a long term, however, as they often cause severe irritation, necessitating their periodic removal and hence interruption of treatment. Thus, the medical community has evolved surgical approaches for treatment of morbid obesity.
[0006] Most surgical procedures for treatment of morbid obesity may generally be classified as either being directed toward the prevention of absorption of food (malabsorption), or restriction of stomach to make the patient feel full (gastric restriction) The most common malabsorption and gastric restriction technique is the gastric bypass. In variations of this technique, the stomach is horizontally divided into two isolated pouches, with the upper pouch having a small food capacity. The upper pouch is connected to the small intestine, or jejunum, through a small stoma, which restricts the processing of food by the greatly reduced useable stomach. Since food bypass much of the intestines, the amount of absorption of food is greatly reduced.
[0007] There are many disadvantages to the above procedure. Typically the above mentioned procedure is performed in an open surgical environment. Current minimally invasive techniques are difficult for surgeons to master, and have many additional drawbacks.
Also, there is a high level of patient uneasiness with the idea of such a drastic procedure which is not easily reversible. In addition, all malabsorption techniques carry ongoing risks and side effects to the patient, including malnutrition and dumping syndrome.
[0008] Consequently, many patients and physicians prefer to undergo a gastric restriction procedure for the treatment of morbid obesity. One of the most common procedures involves the implantation of an adjustable gastric band. Examples of an adjustable gastric band can be found in U.S. Patents 4,592,339 issued to Kuzmak; RE 36176 issued to Kuzmak; 5,226,429 issued to Kuzmak; 6,102,922 issued to Jacobson and 5,601,604 issued to Vincent, all of which are hereby incorporated herein by reference.
In accordance with current practice, a gastric band is operatively placed to encircle the stomach. This divides the stomach into two parts with a stoma in-between. An upper portion, or a pouch, which is relatively small, and a lower portion which is relatively large. The small partitioned portion of the stomach effectively becomes the patients new stomach, requiring very little food to make the patient feel full.
[0009] Once positioned around the stomach, the ends of the gastric band are fastened to one another and the band is held securely in place by folding a portion of the gastric wall over the band and closing the folded tissue with sutures placed therethrough thereby preventing the band from slipping and the encircled stoma from expanding.
Gastric bands typically include a flexible substantially non-extensible portion having an expandable, inflatable portion attached thereto. The inflatable portion is in fluid communication with a remote injection site, or port. Injection or removal of an inflation fluid into or from the interior of the inflatable portion is used to adjust the size of the stoma either during or following implantation. By enlarging the stoma, the patient can eat more food without feeling as full, but will not lose weight as fast. By reducing the size of the stoma, the opposite happens. Physicians regularly adjust the size of stoma to adjust the rate of weight loss.
[0010] For most fluid injection ports for the above described bands are attached underneath the skin to the fascia of a patient. Such ports are often provided with suture holes and the port is sutured to the tissue. However, alternative means of attaching the port to the patient, such as using integral hooks, can be used as well. Such other means for attaching the port to a patient are described in commonly assigned and copending U.S.
Patent Application Serial Numbers: 10/741,785 filed December 19, 2003; 60/478,763 filed December 19, 2003; 10/741,868 filed December 30, 2003; all of which are hereby incorporated herein by reference.
[0011] However, many of the prior art fasteners could cause patient discomfort, including pain.
It is well known that once the port is placed a fibrotic capsule begins to grow over the port until it is completely enclapsuled. The rate at which the fibtutic capsule grows varies from patient to patient, but generally surgeons agree that the port is fully encapsulated after 2 months. Once the port has been captured by the fibrotic capsule, there is no longer a need for the port to be fastened with sutures or other types of fasteners. In fact, it would be desirable if these additional fastening means were no longer part of the port system so as to not cause patient discomfort.
[0012] Summary of the Invention In accordance with the present invention, there is provided an implantable surgical injection port having an undeployed position, and a deployed position wherein it is attached to tissue. The port includes a housing having a closed distal end, a open proximal end and a fluid reservoir therebetween. The port further includes a needle penetrable septum attached to the housing about the opening. The port even further includes at least one attachment mechanism mounted to the housing for initially attaching the port to tissue wherein the attachment mechanism is made from a bioabsorbable material.
Detailed Description of the Drawings [0013] The novel features of the invention are set forth with particularity in the appended claims.
The invention itself, however, both as to organization and methods of operation, together with further objects and advantages thereof, may best be understood by reference to the following description, taken in conjunction with the accompanying drawings in which:
(0014] Figure 1 is a perspective view of a surgically implantable fluid port made in accordance with the present invention, showing the port attached to an adjustable gastric band.
[0015] Figure 2 is a perspective view of a surgically implantable fluid port made in accordance with the present invention.
[0016] Figure 3 is a cross section of the port shown in Figures 1 and 2, taken along Iine 3-3 in Figure I.
(0017] Figure 4 is a view similar to that of Figure 3 but showing the fluid port implanted within a patient.
[0018] Detailed Description of the Invention [0019] Referring now to the drawings wherein like numerals indicate the same elements throughout the views, as stated above there is shown in Figure 1 an adjustable gastric band 1 of the type described in the above mentioned incorporated references.
Band 1 is implanted within a body of a patient to surround the stomach 12. The inflatable portion of the band is in fluid communication with injection port 10 via a catheter tube 52. Tube 52 has a proximal end 53 attached to the port 10 and a distal end 55 attached to adjustable gastric band 1. Port 10 can be used for a wide range of devices in the medical field and not only for gastric bands. For example the port can also used for vascular access for drug delivery.
[0020] As seen from Figures 2 and 3, surgically implantable injection port 10 includes a housing 12. Housing 12 can be made from any number of materials including stainless steel, titanium, or polymeric materials. Housing 12 has a distal back portion or closed distal end 14 and a perimeter wall portion 16 extending proximally from the back portion 14 at an angle. Wall portion 16 defines a proximal opening or open proximal end 18, and a fluid reservoir 20 between opening 18 and back portion 14. The port includes a needle penetrable septum 22 attached to the housing about the opening 18 so as to cover the opening and seal the reservoir 20. Septum 22 can be made from any number of materials including silicone. Septum 22 is preferably placed in a proximal enough position such that the depth of the reservoir 20 is sufficient enough to expose the open tip of a needle, such as a Huber needle, so that fluid transfer can take place. Septum 22 is preferably arranged so that it will self seal after being punctured by a needle and the needle is withdrawn. In one embodiment, the septum is made from silicone which is under compression when attached to the housing. Port 10 further includes a catheter tube connection member 30, in fluid communication with reservoir 20.
[0021] Port 10 is implanted into a patient and attached to the fascia just below the skin of the patient, so that fluid can be inserted and withdrawn from the inflatable portion with a syringe. As seen from the figures, port 1 includes one or more attachment mechanisms 70, taking the form of an arcuate hook. However, for purposes of this invention, the attachment mechanism could take the form of alternative means such as using suture.
Some of these other means for attaching the port to a patient are described in commonly assigned and copending U.S. Patent Application Serial Numbers: 10/741,785 filed December 19, 2003; 60/478,763 filed December 19, 2003; 10/741,868 filed December 30, 2003; all of which are hereby incorporated herein by reference.
[0022] As seen from the figures, port 1 includes one or more attachment mechanisms 70. The figures herein show three attachment mechanisms all substantially identical and equally spaced from each other. Attachment mechanisms 70 are mounted to the housing 12 at a pivot point 80 along an outer periphery 13 of the housing 12. As seen from the figures, attachment mechanisms 70 are arcuate hooks pivotable with respect to the housing.
Attachment mechanisms 70 have an arcuate length L extending substantially greater than 90°, and preferably at least 180° about the pivot point.
Implantable surgical injection port has an undeployed position, shown as a solid line in Figure 3, and a deployed position, shown as the phantom line in Figure 3 and in Figure 4, wherein the port is attached to tissue. Attachment mechanisms 70 is preferably made from a bioabsorbable material including, but not limited to, one or more of the following either alone or in combination:
iron, polydioxanone, polyglactin and/or poliglecaprone.
[0023] Attachment mechanism 70 has a fixed end 72 pivotally attached to the housing 12 at pivot point 80. The design allows a surgeon to use forceps and drive the fastener through the tissue until the free end 74 rests against the flat 75. In this way the patient is protected from the sharp end of the tip. Attachment mechanism 70 also includes a free end 74 which has a sharp or pointed configuration. Housing 12 further includes at least one recessed portion 15 along its distal end 14. Recessed portion 15 is designed to receive the free end 74 of attachment mechanisms 70 when the port 1 is in its deployed position. This design prevents any exposure of the sharp free end to tissue after the port has been implanted.
[0024] The above described 180° hook or attachment mechanisms provide advantages over prior 90° or less hooks. As seen from Figure 4, the above described attachment mechanism allows the hook to engage a greater area of tissue, and allows for two locking points, entry into and then out of the fascia. This provides for better sacrament of the port to the tissue. Further no "sharp" is exposed to the patient. A further advantage of the fastener configuration is that the fastener follows a constant radius when pushing through the tissue. By maintaining a constant radius the fastener never induces a compressive force onto the fascia. This should minimize pain because the fastener is not "compressing or squeezing" nerves.
[0025] In practice, the physician would create an incision in the skin 110 of a patient to expose the fascia according to well known surgical techniques. Thereafter, as seen from Figure 4, the port 1 could be placed against the fascia 100 of the patient with the port in its undeployed position. Thereafter, the physician could rotate, manually or otherwise, the attachment mechanism substantially greater than 90° and preferably at least 180° so that the hook enters and then exits the fascia. The design allows a surgeon to use forceps and drive the fastener through the tissue until the free end 74 rests against the flat 75. In this way the patient is protected from the sharp end of the tip. This could be done for each attachment mechanism on the device. Thereafter, the catheter tube 52 would be connected to connection member 30, and the patient is sewn up.
[0026) It will become readily apparent to those skilled in the art that the above invention has equally applicability to other types of implantable bands. For example, bands are used for the treatment of fecal incontinence. One such band is described in U.S.
Patent 6,461,292 which is hereby incorporated herein by reference. Bands can also be used to treat urinary incontinence. One such band is described in U.S. Patent Application 2003/0105385 which is hereby incorporated herein by reference. Bands can also be used to treat heartburn and/or acid reflux. One such band is described in U.S.
Patent 6,470,892 which is hereby incorporated herein by reference. Bands can also be used to treat impotence. One such band is described in U.S. Patent Application 2003/0114729 which is hereby incorporated herein by reference.
[0027) While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. For example, as would be apparent to those skilled in the art, the disclosures herein have equal application in robotic-assisted surgery. In addition, it should be understood that every structure described above has a function and such structure can be referred to as a means for performing that function. Accordingly, it is intended that the invention be limited only by the spirit and scope of the appended claims.
[OOOS] Numerous non-operative therapies for morbid obesity have been tried with virtually no permanent success. Dietary counseling, behavior modification, wiring a patient's jaws shut, and pharmacological methods have all been tried, and failed to correct the condition. Mechanical apparatuses for insertion into the body through non-surgical means, such as the use of gastric balloons to fill the stomach have also been employed in the treatment of the condition. Such devices cannot be employed over a long term, however, as they often cause severe irritation, necessitating their periodic removal and hence interruption of treatment. Thus, the medical community has evolved surgical approaches for treatment of morbid obesity.
[0006] Most surgical procedures for treatment of morbid obesity may generally be classified as either being directed toward the prevention of absorption of food (malabsorption), or restriction of stomach to make the patient feel full (gastric restriction) The most common malabsorption and gastric restriction technique is the gastric bypass. In variations of this technique, the stomach is horizontally divided into two isolated pouches, with the upper pouch having a small food capacity. The upper pouch is connected to the small intestine, or jejunum, through a small stoma, which restricts the processing of food by the greatly reduced useable stomach. Since food bypass much of the intestines, the amount of absorption of food is greatly reduced.
[0007] There are many disadvantages to the above procedure. Typically the above mentioned procedure is performed in an open surgical environment. Current minimally invasive techniques are difficult for surgeons to master, and have many additional drawbacks.
Also, there is a high level of patient uneasiness with the idea of such a drastic procedure which is not easily reversible. In addition, all malabsorption techniques carry ongoing risks and side effects to the patient, including malnutrition and dumping syndrome.
[0008] Consequently, many patients and physicians prefer to undergo a gastric restriction procedure for the treatment of morbid obesity. One of the most common procedures involves the implantation of an adjustable gastric band. Examples of an adjustable gastric band can be found in U.S. Patents 4,592,339 issued to Kuzmak; RE 36176 issued to Kuzmak; 5,226,429 issued to Kuzmak; 6,102,922 issued to Jacobson and 5,601,604 issued to Vincent, all of which are hereby incorporated herein by reference.
In accordance with current practice, a gastric band is operatively placed to encircle the stomach. This divides the stomach into two parts with a stoma in-between. An upper portion, or a pouch, which is relatively small, and a lower portion which is relatively large. The small partitioned portion of the stomach effectively becomes the patients new stomach, requiring very little food to make the patient feel full.
[0009] Once positioned around the stomach, the ends of the gastric band are fastened to one another and the band is held securely in place by folding a portion of the gastric wall over the band and closing the folded tissue with sutures placed therethrough thereby preventing the band from slipping and the encircled stoma from expanding.
Gastric bands typically include a flexible substantially non-extensible portion having an expandable, inflatable portion attached thereto. The inflatable portion is in fluid communication with a remote injection site, or port. Injection or removal of an inflation fluid into or from the interior of the inflatable portion is used to adjust the size of the stoma either during or following implantation. By enlarging the stoma, the patient can eat more food without feeling as full, but will not lose weight as fast. By reducing the size of the stoma, the opposite happens. Physicians regularly adjust the size of stoma to adjust the rate of weight loss.
[0010] For most fluid injection ports for the above described bands are attached underneath the skin to the fascia of a patient. Such ports are often provided with suture holes and the port is sutured to the tissue. However, alternative means of attaching the port to the patient, such as using integral hooks, can be used as well. Such other means for attaching the port to a patient are described in commonly assigned and copending U.S.
Patent Application Serial Numbers: 10/741,785 filed December 19, 2003; 60/478,763 filed December 19, 2003; 10/741,868 filed December 30, 2003; all of which are hereby incorporated herein by reference.
[0011] However, many of the prior art fasteners could cause patient discomfort, including pain.
It is well known that once the port is placed a fibrotic capsule begins to grow over the port until it is completely enclapsuled. The rate at which the fibtutic capsule grows varies from patient to patient, but generally surgeons agree that the port is fully encapsulated after 2 months. Once the port has been captured by the fibrotic capsule, there is no longer a need for the port to be fastened with sutures or other types of fasteners. In fact, it would be desirable if these additional fastening means were no longer part of the port system so as to not cause patient discomfort.
[0012] Summary of the Invention In accordance with the present invention, there is provided an implantable surgical injection port having an undeployed position, and a deployed position wherein it is attached to tissue. The port includes a housing having a closed distal end, a open proximal end and a fluid reservoir therebetween. The port further includes a needle penetrable septum attached to the housing about the opening. The port even further includes at least one attachment mechanism mounted to the housing for initially attaching the port to tissue wherein the attachment mechanism is made from a bioabsorbable material.
Detailed Description of the Drawings [0013] The novel features of the invention are set forth with particularity in the appended claims.
The invention itself, however, both as to organization and methods of operation, together with further objects and advantages thereof, may best be understood by reference to the following description, taken in conjunction with the accompanying drawings in which:
(0014] Figure 1 is a perspective view of a surgically implantable fluid port made in accordance with the present invention, showing the port attached to an adjustable gastric band.
[0015] Figure 2 is a perspective view of a surgically implantable fluid port made in accordance with the present invention.
[0016] Figure 3 is a cross section of the port shown in Figures 1 and 2, taken along Iine 3-3 in Figure I.
(0017] Figure 4 is a view similar to that of Figure 3 but showing the fluid port implanted within a patient.
[0018] Detailed Description of the Invention [0019] Referring now to the drawings wherein like numerals indicate the same elements throughout the views, as stated above there is shown in Figure 1 an adjustable gastric band 1 of the type described in the above mentioned incorporated references.
Band 1 is implanted within a body of a patient to surround the stomach 12. The inflatable portion of the band is in fluid communication with injection port 10 via a catheter tube 52. Tube 52 has a proximal end 53 attached to the port 10 and a distal end 55 attached to adjustable gastric band 1. Port 10 can be used for a wide range of devices in the medical field and not only for gastric bands. For example the port can also used for vascular access for drug delivery.
[0020] As seen from Figures 2 and 3, surgically implantable injection port 10 includes a housing 12. Housing 12 can be made from any number of materials including stainless steel, titanium, or polymeric materials. Housing 12 has a distal back portion or closed distal end 14 and a perimeter wall portion 16 extending proximally from the back portion 14 at an angle. Wall portion 16 defines a proximal opening or open proximal end 18, and a fluid reservoir 20 between opening 18 and back portion 14. The port includes a needle penetrable septum 22 attached to the housing about the opening 18 so as to cover the opening and seal the reservoir 20. Septum 22 can be made from any number of materials including silicone. Septum 22 is preferably placed in a proximal enough position such that the depth of the reservoir 20 is sufficient enough to expose the open tip of a needle, such as a Huber needle, so that fluid transfer can take place. Septum 22 is preferably arranged so that it will self seal after being punctured by a needle and the needle is withdrawn. In one embodiment, the septum is made from silicone which is under compression when attached to the housing. Port 10 further includes a catheter tube connection member 30, in fluid communication with reservoir 20.
[0021] Port 10 is implanted into a patient and attached to the fascia just below the skin of the patient, so that fluid can be inserted and withdrawn from the inflatable portion with a syringe. As seen from the figures, port 1 includes one or more attachment mechanisms 70, taking the form of an arcuate hook. However, for purposes of this invention, the attachment mechanism could take the form of alternative means such as using suture.
Some of these other means for attaching the port to a patient are described in commonly assigned and copending U.S. Patent Application Serial Numbers: 10/741,785 filed December 19, 2003; 60/478,763 filed December 19, 2003; 10/741,868 filed December 30, 2003; all of which are hereby incorporated herein by reference.
[0022] As seen from the figures, port 1 includes one or more attachment mechanisms 70. The figures herein show three attachment mechanisms all substantially identical and equally spaced from each other. Attachment mechanisms 70 are mounted to the housing 12 at a pivot point 80 along an outer periphery 13 of the housing 12. As seen from the figures, attachment mechanisms 70 are arcuate hooks pivotable with respect to the housing.
Attachment mechanisms 70 have an arcuate length L extending substantially greater than 90°, and preferably at least 180° about the pivot point.
Implantable surgical injection port has an undeployed position, shown as a solid line in Figure 3, and a deployed position, shown as the phantom line in Figure 3 and in Figure 4, wherein the port is attached to tissue. Attachment mechanisms 70 is preferably made from a bioabsorbable material including, but not limited to, one or more of the following either alone or in combination:
iron, polydioxanone, polyglactin and/or poliglecaprone.
[0023] Attachment mechanism 70 has a fixed end 72 pivotally attached to the housing 12 at pivot point 80. The design allows a surgeon to use forceps and drive the fastener through the tissue until the free end 74 rests against the flat 75. In this way the patient is protected from the sharp end of the tip. Attachment mechanism 70 also includes a free end 74 which has a sharp or pointed configuration. Housing 12 further includes at least one recessed portion 15 along its distal end 14. Recessed portion 15 is designed to receive the free end 74 of attachment mechanisms 70 when the port 1 is in its deployed position. This design prevents any exposure of the sharp free end to tissue after the port has been implanted.
[0024] The above described 180° hook or attachment mechanisms provide advantages over prior 90° or less hooks. As seen from Figure 4, the above described attachment mechanism allows the hook to engage a greater area of tissue, and allows for two locking points, entry into and then out of the fascia. This provides for better sacrament of the port to the tissue. Further no "sharp" is exposed to the patient. A further advantage of the fastener configuration is that the fastener follows a constant radius when pushing through the tissue. By maintaining a constant radius the fastener never induces a compressive force onto the fascia. This should minimize pain because the fastener is not "compressing or squeezing" nerves.
[0025] In practice, the physician would create an incision in the skin 110 of a patient to expose the fascia according to well known surgical techniques. Thereafter, as seen from Figure 4, the port 1 could be placed against the fascia 100 of the patient with the port in its undeployed position. Thereafter, the physician could rotate, manually or otherwise, the attachment mechanism substantially greater than 90° and preferably at least 180° so that the hook enters and then exits the fascia. The design allows a surgeon to use forceps and drive the fastener through the tissue until the free end 74 rests against the flat 75. In this way the patient is protected from the sharp end of the tip. This could be done for each attachment mechanism on the device. Thereafter, the catheter tube 52 would be connected to connection member 30, and the patient is sewn up.
[0026) It will become readily apparent to those skilled in the art that the above invention has equally applicability to other types of implantable bands. For example, bands are used for the treatment of fecal incontinence. One such band is described in U.S.
Patent 6,461,292 which is hereby incorporated herein by reference. Bands can also be used to treat urinary incontinence. One such band is described in U.S. Patent Application 2003/0105385 which is hereby incorporated herein by reference. Bands can also be used to treat heartburn and/or acid reflux. One such band is described in U.S.
Patent 6,470,892 which is hereby incorporated herein by reference. Bands can also be used to treat impotence. One such band is described in U.S. Patent Application 2003/0114729 which is hereby incorporated herein by reference.
[0027) While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. For example, as would be apparent to those skilled in the art, the disclosures herein have equal application in robotic-assisted surgery. In addition, it should be understood that every structure described above has a function and such structure can be referred to as a means for performing that function. Accordingly, it is intended that the invention be limited only by the spirit and scope of the appended claims.
Claims (19)
1. An implantable surgical injection port having an undeployed position, and a deployed position wherein it is attached to tissue, said port comprising:
a. a housing having a closed distal end, a open proximal end and a fluid reservoir therebetween;
b. a needle penetrable septum attached to said housing about said opening; and c. at least one attachment mechanism mounted to said housing for initially attaching said port to tissue, said attachment mechanism comprising a bioabsorbable material.
a. a housing having a closed distal end, a open proximal end and a fluid reservoir therebetween;
b. a needle penetrable septum attached to said housing about said opening; and c. at least one attachment mechanism mounted to said housing for initially attaching said port to tissue, said attachment mechanism comprising a bioabsorbable material.
2. The injection port of claim 1 wherein said attachment mechanism comprises an arcuate hook pivotable with respect to said housing, said hook having a fixed end attached to said housing and a free end, said arcuate hook having a length extending substantially at least 180° about said pivot point.
3. The injection port of claim 1 wherein said attachment mechanism comprises an arcuate hook pivotable with respect to said housing, said hook having a fixed end attached to said housing and a free end, said arcuate hook having a length extending substantially greater than 90° about said pivot point.
4. The injection port of claim 1 wherein said attachment mechanism comprises polyglactin.
5. The injection port of claim 1 wherein said attachment mechanism comprises poliglecaprone.
6. The injection port of claim 1 wherein said attachment mechanism comprises iron.
7. The injection port of claim 1 further including a catheter connection tube attached to said housing and in fluid communication with said reservoir.
8. The injection port of claim 1 wherein said housing comprises titanium.
9. The injection port of claim 1 wherein said septum self seals after being punctured by a needle and the needle is withdrawn.
10. The injection port of claim 1 wherein said septum comprises silicone.
11. An implantable surgical injection port having an undeployed position, and a deployed position wherein it is attached to tissue, said port comprising:
a. a housing having a closed distal end, a open proximal end and a fluid reservoir therebetween;
b. a needle penetrable septum attached to said housing about said opening;
c. at least one attachment mechanism mounted to said housing for initially attaching said port to tissue, said attachment mechanism comprising a bioabsorbable material; and d. an adjustable gastric band attached to said housing via a catheter connection tube attached to said housing and in fluid communication with said reservoir.
a. a housing having a closed distal end, a open proximal end and a fluid reservoir therebetween;
b. a needle penetrable septum attached to said housing about said opening;
c. at least one attachment mechanism mounted to said housing for initially attaching said port to tissue, said attachment mechanism comprising a bioabsorbable material; and d. an adjustable gastric band attached to said housing via a catheter connection tube attached to said housing and in fluid communication with said reservoir.
12. The injection port of claim 11 wherein said attachment mechanism comprises an arcuate hook pivotable with respect to said housing, said hook having a fixed end attached to said housing and a free end, said arcuate hook having a length extending substantially at least 180° about said pivot point.
13. The injection port of claim 11 wherein said attachment mechanism comprises an arcuate hook pivotable with respect to said housing, said hook having a fixed end attached to said housing and a free end, said arcuate hook having a length extending substantially greater than 90° about said pivot point.
14. The injection port of claim 11 wherein said attachment mechanism comprises polyglactin.
15. The injection port of claim 11 wherein said attachment mechanism comprises poliglecaprone.
16. The injection port of claim 11 wherein said attachment mechanism comprises polydioxanone.
17. The injection port of claim 11 wherein said attachment mechanism comprises iron.
18. The injection port of claim 11 wherein said housing comprises titanium.
19. The injection port of claim 1 wherein said septum self seals after being punctured by a needle and the needle is withdrawn.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/048,155 | 2005-02-01 | ||
| US11/048,155 US20060173424A1 (en) | 2005-02-01 | 2005-02-01 | Surgically implantable injection port having an absorbable fastener |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2534515A1 true CA2534515A1 (en) | 2006-08-01 |
| CA2534515C CA2534515C (en) | 2013-05-14 |
Family
ID=36128406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2534515A Expired - Fee Related CA2534515C (en) | 2005-02-01 | 2006-01-31 | A surgically implantable injection port having an absorbable fastener |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20060173424A1 (en) |
| EP (1) | EP1685873B1 (en) |
| JP (1) | JP5000142B2 (en) |
| KR (1) | KR20060088503A (en) |
| CN (1) | CN1820717B (en) |
| AT (1) | ATE389433T1 (en) |
| AU (2) | AU2006200165B2 (en) |
| BR (1) | BRPI0600216A (en) |
| CA (1) | CA2534515C (en) |
| DE (1) | DE602006000715T2 (en) |
| ES (1) | ES2302562T3 (en) |
| HK (1) | HK1092742A1 (en) |
| PL (1) | PL1685873T3 (en) |
| RU (1) | RU2006102933A (en) |
| SG (1) | SG124380A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD780309S1 (en) * | 2015-04-16 | 2017-02-28 | Axcess Instruments, Inc. | Single site surgical uniport |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8177762B2 (en) | 1998-12-07 | 2012-05-15 | C. R. Bard, Inc. | Septum including at least one identifiable feature, access ports including same, and related methods |
| US7338433B2 (en) | 2002-08-13 | 2008-03-04 | Allergan, Inc. | Remotely adjustable gastric banding method |
| DE60331457D1 (en) | 2002-08-28 | 2010-04-08 | Allergan Inc | TEMPTING MAGNETIC BANDING DEVICE |
| WO2005037055A2 (en) * | 2003-09-15 | 2005-04-28 | Inamed Medical Products Corporation | Implantable device fastening system and methods of use |
| JP2007527279A (en) | 2004-01-23 | 2007-09-27 | アラーガン、インコーポレイテッド | One-piece adjustable gastric band that can be fixed removably |
| ES2375930T5 (en) * | 2004-01-23 | 2014-10-31 | Apollo Endosurgery, Inc. | Implantable device fixation system |
| ES2333024T3 (en) | 2004-03-08 | 2010-02-16 | Allergan Medical S.A. | CLOSURE SYSTEM FOR TUBULAR ORGANS. |
| ATE517652T1 (en) | 2004-03-18 | 2011-08-15 | Allergan Inc | DEVICE FOR ADJUSTING THE VOLUME OF INTRAGASTRAL BALLOONS |
| US7909804B2 (en) * | 2005-02-07 | 2011-03-22 | C. R. Bard, Inc. | Vascular access port with integral attachment mechanism |
| US8029482B2 (en) | 2005-03-04 | 2011-10-04 | C. R. Bard, Inc. | Systems and methods for radiographically identifying an access port |
| US9474888B2 (en) | 2005-03-04 | 2016-10-25 | C. R. Bard, Inc. | Implantable access port including a sandwiched radiopaque insert |
| WO2006096686A1 (en) | 2005-03-04 | 2006-09-14 | C.R. Bard, Inc. | Access port identification systems and methods |
| US7947022B2 (en) | 2005-03-04 | 2011-05-24 | C. R. Bard, Inc. | Access port identification systems and methods |
| US8251888B2 (en) | 2005-04-13 | 2012-08-28 | Mitchell Steven Roslin | Artificial gastric valve |
| US10307581B2 (en) | 2005-04-27 | 2019-06-04 | C. R. Bard, Inc. | Reinforced septum for an implantable medical device |
| US8147455B2 (en) | 2005-04-27 | 2012-04-03 | C. R. Bard, Inc. | Infusion apparatuses and methods of use |
| EP1896117B1 (en) | 2005-04-27 | 2011-01-12 | C.R.Bard, Inc. | Power injector system for injecting contrast media into an intravenous line |
| US7798954B2 (en) | 2006-01-04 | 2010-09-21 | Allergan, Inc. | Hydraulic gastric band with collapsible reservoir |
| US8043206B2 (en) | 2006-01-04 | 2011-10-25 | Allergan, Inc. | Self-regulating gastric band with pressure data processing |
| US9265912B2 (en) | 2006-11-08 | 2016-02-23 | C. R. Bard, Inc. | Indicia informative of characteristics of insertable medical devices |
| US9642986B2 (en) | 2006-11-08 | 2017-05-09 | C. R. Bard, Inc. | Resource information key for an insertable medical device |
| US8257325B2 (en) | 2007-06-20 | 2012-09-04 | Medical Components, Inc. | Venous access port with molded and/or radiopaque indicia |
| US9610432B2 (en) | 2007-07-19 | 2017-04-04 | Innovative Medical Devices, Llc | Venous access port assembly with X-ray discernable indicia |
| EP2180915B1 (en) | 2007-07-19 | 2017-10-04 | Medical Components, Inc. | Venous access port assembly with x-ray discernable indicia |
| US9579496B2 (en) | 2007-11-07 | 2017-02-28 | C. R. Bard, Inc. | Radiopaque and septum-based indicators for a multi-lumen implantable port |
| NZ588818A (en) | 2008-04-17 | 2012-10-26 | Allergan Inc | Body implantable access port device activated by a cable mechanism |
| US9023063B2 (en) | 2008-04-17 | 2015-05-05 | Apollo Endosurgery, Inc. | Implantable access port device having a safety cap |
| US8292800B2 (en) | 2008-06-11 | 2012-10-23 | Allergan, Inc. | Implantable pump system |
| EP2362762A1 (en) | 2008-10-06 | 2011-09-07 | Allergan Medical Sàrl | Mechanical gastric band with cushions |
| US20100185049A1 (en) | 2008-10-22 | 2010-07-22 | Allergan, Inc. | Dome and screw valves for remotely adjustable gastric banding systems |
| WO2010051494A1 (en) | 2008-10-31 | 2010-05-06 | C.R. Bard, Inc. | Systems and methods for identifying an acess port |
| US11890443B2 (en) | 2008-11-13 | 2024-02-06 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
| US8932271B2 (en) | 2008-11-13 | 2015-01-13 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
| EP2451512A1 (en) | 2009-07-07 | 2012-05-16 | C.R. Bard Inc. | Extensible internal bolster for a medical device |
| US8715158B2 (en) | 2009-08-26 | 2014-05-06 | Apollo Endosurgery, Inc. | Implantable bottom exit port |
| US8708979B2 (en) | 2009-08-26 | 2014-04-29 | Apollo Endosurgery, Inc. | Implantable coupling device |
| US8506532B2 (en) | 2009-08-26 | 2013-08-13 | Allergan, Inc. | System including access port and applicator tool |
| JP2013510652A (en) | 2009-11-17 | 2013-03-28 | シー・アール・バード・インコーポレーテッド | Overmolded access port including locking feature and identification feature |
| US8882728B2 (en) | 2010-02-10 | 2014-11-11 | Apollo Endosurgery, Inc. | Implantable injection port |
| US8678993B2 (en) | 2010-02-12 | 2014-03-25 | Apollo Endosurgery, Inc. | Remotely adjustable gastric banding system |
| US8758221B2 (en) | 2010-02-24 | 2014-06-24 | Apollo Endosurgery, Inc. | Source reservoir with potential energy for remotely adjustable gastric banding system |
| US8840541B2 (en) | 2010-02-25 | 2014-09-23 | Apollo Endosurgery, Inc. | Pressure sensing gastric banding system |
| US8764624B2 (en) | 2010-02-25 | 2014-07-01 | Apollo Endosurgery, Inc. | Inductively powered remotely adjustable gastric banding system |
| US10166380B2 (en) * | 2010-04-12 | 2019-01-01 | Po-Jen Ko | Implantable venous device |
| US8939888B2 (en) | 2010-04-28 | 2015-01-27 | Apollo Endosurgery, Inc. | Method and system for determining the pressure of a fluid in a syringe, an access port, a catheter, and a gastric band |
| US9028394B2 (en) | 2010-04-29 | 2015-05-12 | Apollo Endosurgery, Inc. | Self-adjusting mechanical gastric band |
| US20110270024A1 (en) | 2010-04-29 | 2011-11-03 | Allergan, Inc. | Self-adjusting gastric band having various compliant components |
| US9044298B2 (en) | 2010-04-29 | 2015-06-02 | Apollo Endosurgery, Inc. | Self-adjusting gastric band |
| US20110270021A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Electronically enhanced access port for a fluid filled implant |
| US20110270025A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Remotely powered remotely adjustable gastric band system |
| US8992415B2 (en) | 2010-04-30 | 2015-03-31 | Apollo Endosurgery, Inc. | Implantable device to protect tubing from puncture |
| US9226840B2 (en) | 2010-06-03 | 2016-01-05 | Apollo Endosurgery, Inc. | Magnetically coupled implantable pump system and method |
| US8517915B2 (en) | 2010-06-10 | 2013-08-27 | Allergan, Inc. | Remotely adjustable gastric banding system |
| US20120041258A1 (en) | 2010-08-16 | 2012-02-16 | Allergan, Inc. | Implantable access port system |
| US9211207B2 (en) | 2010-08-18 | 2015-12-15 | Apollo Endosurgery, Inc. | Power regulated implant |
| US8698373B2 (en) | 2010-08-18 | 2014-04-15 | Apollo Endosurgery, Inc. | Pare piezo power with energy recovery |
| US20120059216A1 (en) | 2010-09-07 | 2012-03-08 | Allergan, Inc. | Remotely adjustable gastric banding system |
| US20120065460A1 (en) | 2010-09-14 | 2012-03-15 | Greg Nitka | Implantable access port system |
| US8961393B2 (en) | 2010-11-15 | 2015-02-24 | Apollo Endosurgery, Inc. | Gastric band devices and drive systems |
| USD676955S1 (en) | 2010-12-30 | 2013-02-26 | C. R. Bard, Inc. | Implantable access port |
| USD682416S1 (en) | 2010-12-30 | 2013-05-14 | C. R. Bard, Inc. | Implantable access port |
| EP2688605A4 (en) | 2011-03-24 | 2014-09-10 | Bard Inc C R | Fixation and protection of an implanted medical device |
| US8725435B2 (en) | 2011-04-13 | 2014-05-13 | Apollo Endosurgery, Inc. | Syringe-based leak detection system |
| US8821373B2 (en) | 2011-05-10 | 2014-09-02 | Apollo Endosurgery, Inc. | Directionless (orientation independent) needle injection port |
| US8801597B2 (en) | 2011-08-25 | 2014-08-12 | Apollo Endosurgery, Inc. | Implantable access port with mesh attachment rivets |
| US9199069B2 (en) | 2011-10-20 | 2015-12-01 | Apollo Endosurgery, Inc. | Implantable injection port |
| US8858421B2 (en) | 2011-11-15 | 2014-10-14 | Apollo Endosurgery, Inc. | Interior needle stick guard stems for tubes |
| US9089395B2 (en) * | 2011-11-16 | 2015-07-28 | Appolo Endosurgery, Inc. | Pre-loaded septum for use with an access port |
| US8876694B2 (en) | 2011-12-07 | 2014-11-04 | Apollo Endosurgery, Inc. | Tube connector with a guiding tip |
| US8961394B2 (en) | 2011-12-20 | 2015-02-24 | Apollo Endosurgery, Inc. | Self-sealing fluid joint for use with a gastric band |
| JP2014039720A (en) * | 2012-08-23 | 2014-03-06 | Keisei Ika Kogyo Kk | Suture needle and method for manufacturing the same |
| JP6487339B2 (en) | 2013-01-23 | 2019-03-20 | シー・アール・バード・インコーポレーテッドＣ Ｒ Ｂａｒｄ Ｉｎｃｏｒｐｏｒａｔｅｄ | Low profile access port |
| US11464960B2 (en) | 2013-01-23 | 2022-10-11 | C. R. Bard, Inc. | Low-profile single and dual vascular access device |
| US11420033B2 (en) | 2013-01-23 | 2022-08-23 | C. R. Bard, Inc. | Low-profile single and dual vascular access device |
| USD870264S1 (en) | 2017-09-06 | 2019-12-17 | C. R. Bard, Inc. | Implantable apheresis port |
| KR102494088B1 (en) * | 2017-09-14 | 2023-02-01 | 주식회사 플라즈맵 | Sterilizer and Sterilization Process Utilizing Impermeable Film Pouch |
| CA3163336A1 (en) * | 2019-12-12 | 2021-06-17 | Fresenius Medical Care Holdings, Inc. | An injection port for connecting with a medical fluid container and methods for the production of same |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4592339A (en) * | 1985-06-12 | 1986-06-03 | Mentor Corporation | Gastric banding device |
| US4673394A (en) * | 1986-01-17 | 1987-06-16 | Strato Medical Corporation | Implantable treatment reservoir |
| US5324307A (en) * | 1990-07-06 | 1994-06-28 | American Cyanamid Company | Polymeric surgical staple |
| US5653718A (en) * | 1994-05-16 | 1997-08-05 | Yoon; Inbae | Cannula anchoring system |
| US6086608A (en) * | 1996-02-22 | 2000-07-11 | Smith & Nephew, Inc. | Suture collet |
| DE19702708C1 (en) * | 1997-01-16 | 1998-08-27 | Ethicon Gmbh | Process for treating hydrolyzable resorbable surgical sutures |
| US5908429A (en) * | 1997-05-01 | 1999-06-01 | Yoon; Inbae | Methods of anatomical tissue ligation |
| US5848989A (en) * | 1997-06-05 | 1998-12-15 | Davinci Biomedical Research Products, Inc. | Implantable port with low profile housing for delivery/collection of fluids and implantation method |
| DE19731021A1 (en) * | 1997-07-18 | 1999-01-21 | Meyer Joerg | In vivo degradable metallic implant |
| DE19751791A1 (en) * | 1997-11-22 | 1999-05-27 | Arnold Dipl Ing Dr Med Pier | Surgical stapling instrument with handle and control |
| JP3779674B2 (en) * | 2002-11-18 | 2006-05-31 | 泉工医科工業株式会社 | Distal tip for stem positioning of artificial joints |
| DE10259411A1 (en) * | 2002-12-19 | 2004-07-08 | Forschungszentrum Karlsruhe Gmbh | Medical clip and device for applying such a device |
| US7862546B2 (en) * | 2003-06-16 | 2011-01-04 | Ethicon Endo-Surgery, Inc. | Subcutaneous self attaching injection port with integral moveable retention members |
| CN1317998C (en) * | 2003-09-04 | 2007-05-30 | 马剑文<Del/> | Degradable medical tissue suture piece |
| WO2005037055A2 (en) * | 2003-09-15 | 2005-04-28 | Inamed Medical Products Corporation | Implantable device fastening system and methods of use |
| US20050148963A1 (en) * | 2004-01-05 | 2005-07-07 | Brennan H. G. | Bioabsorbable surgical sponge |
| US20060015144A1 (en) * | 2004-07-19 | 2006-01-19 | Vascular Control Systems, Inc. | Uterine artery occlusion staple |
| US20070055305A1 (en) * | 2004-09-23 | 2007-03-08 | Guido Schnyder | Biodegradable and/or bioabsorbable member for vascular sealing |
-
2005
- 2005-02-01 US US11/048,155 patent/US20060173424A1/en not_active Abandoned
-
2006
- 2006-01-16 AU AU2006200165A patent/AU2006200165B2/en not_active Ceased
- 2006-01-19 SG SG200600379A patent/SG124380A1/en unknown
- 2006-01-31 AT AT06250529T patent/ATE389433T1/en not_active IP Right Cessation
- 2006-01-31 CA CA2534515A patent/CA2534515C/en not_active Expired - Fee Related
- 2006-01-31 DE DE602006000715T patent/DE602006000715T2/en active Active
- 2006-01-31 JP JP2006023278A patent/JP5000142B2/en active Active
- 2006-01-31 ES ES06250529T patent/ES2302562T3/en active Active
- 2006-01-31 EP EP06250529A patent/EP1685873B1/en not_active Not-in-force
- 2006-01-31 PL PL06250529T patent/PL1685873T3/en unknown
- 2006-02-01 BR BRPI0600216-1A patent/BRPI0600216A/en not_active IP Right Cessation
- 2006-02-01 RU RU2006102933/14A patent/RU2006102933A/en not_active Application Discontinuation
- 2006-02-01 KR KR1020060009622A patent/KR20060088503A/en not_active Application Discontinuation
- 2006-02-05 CN CN2006100033180A patent/CN1820717B/en not_active Expired - Fee Related
- 2006-12-07 HK HK06113501A patent/HK1092742A1/en not_active IP Right Cessation
-
2007
- 2007-05-18 AU AU2007202249A patent/AU2007202249B2/en not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD780309S1 (en) * | 2015-04-16 | 2017-02-28 | Axcess Instruments, Inc. | Single site surgical uniport |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007202249B2 (en) | 2012-07-26 |
| JP5000142B2 (en) | 2012-08-15 |
| AU2007202249A1 (en) | 2007-12-06 |
| AU2006200165A1 (en) | 2006-08-17 |
| DE602006000715T2 (en) | 2009-04-23 |
| ES2302562T3 (en) | 2008-07-16 |
| BRPI0600216A (en) | 2006-09-19 |
| HK1092742A1 (en) | 2007-02-16 |
| ATE389433T1 (en) | 2008-04-15 |
| KR20060088503A (en) | 2006-08-04 |
| DE602006000715D1 (en) | 2008-04-30 |
| AU2006200165B2 (en) | 2012-06-21 |
| US20060173424A1 (en) | 2006-08-03 |
| PL1685873T3 (en) | 2008-08-29 |
| RU2006102933A (en) | 2007-08-10 |
| CN1820717A (en) | 2006-08-23 |
| EP1685873A1 (en) | 2006-08-02 |
| SG124380A1 (en) | 2006-08-30 |
| EP1685873B1 (en) | 2008-03-19 |
| JP2006212432A (en) | 2006-08-17 |
| CN1820717B (en) | 2010-09-22 |
| CA2534515C (en) | 2013-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2534515C (en) | A surgically implantable injection port having an absorbable fastener | |
| CA2508648C (en) | A surgically implantable injection port having an improved fastener | |
| US8585662B2 (en) | Method of implanting a fluid injection port | |
| US20070208313A1 (en) | Method of implanting a fluid injection port | |
| US20060173423A1 (en) | Method for surgically implanting a fluid injection port | |
| CA2497523C (en) | A surgically implantable adjustable band having a flat profile when implanted | |
| US7594885B2 (en) | Method for implanting an adjustable band | |
| US20050240156A1 (en) | Method of implanting a fluid injection port | |
| US20050240155A1 (en) | Surgically implantable injection port having a centered catheter connection tube | |
| CA2521213C (en) | An improved fluid adjustable band | |
| MXPA06001266A (en) | Surgically implantable injection port having an absorbable fastener |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20210201 |